• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
MHC class I transactivator NLRC5 in host immunity, cancer and beyond.MHC Ⅰ类转录激活因子 NLRC5 在宿主免疫、癌症及其他方面的作用
Immunology. 2021 Mar;162(3):252-261. doi: 10.1111/imm.13235. Epub 2020 Aug 3.
2
Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance.I 类转录激活物 NLRC5:MHC I 类途径和癌症免疫监视的核心参与者。
Immunogenetics. 2019 Mar;71(3):273-282. doi: 10.1007/s00251-019-01106-z. Epub 2019 Jan 31.
3
NLRC5: a newly discovered MHC class I transactivator (CITA).NLRC5:一种新发现的 MHC Ⅰ类转录激活物(CITA)。
Microbes Infect. 2012 Jun;14(6):477-84. doi: 10.1016/j.micinf.2011.12.007. Epub 2011 Dec 22.
4
FBXO11 constitutes a major negative regulator of MHC class II through ubiquitin-dependent proteasomal degradation of CIITA.FBXO11 通过泛素依赖性蛋白酶体降解 CIITA 构成 MHC Ⅱ类的主要负调控因子。
Proc Natl Acad Sci U S A. 2023 Jun 13;120(24):e2218955120. doi: 10.1073/pnas.2218955120. Epub 2023 Jun 6.
5
Regulation of class I major histocompatibility complex (MHC) by nucleotide-binding domain, leucine-rich repeat-containing (NLR) proteins.核苷酸结合域、富含亮氨酸重复序列的 NLR 蛋白对 I 类主要组织相容性复合物 (MHC)的调控。
J Biol Chem. 2012 Jul 13;287(29):24294-303. doi: 10.1074/jbc.M112.364604. Epub 2012 May 29.
6
NLRC5/MHC class I transactivator is a target for immune evasion in cancer.NLRC5/主要组织相容性复合体I类反式激活因子是癌症免疫逃逸的一个靶点。
Proc Natl Acad Sci U S A. 2016 May 24;113(21):5999-6004. doi: 10.1073/pnas.1602069113. Epub 2016 May 9.
7
NLRC5: a key regulator of MHC class I-dependent immune responses.NLRC5:MHC I 类依赖性免疫反应的关键调节因子。
Nat Rev Immunol. 2012 Dec;12(12):813-20. doi: 10.1038/nri3339.
8
Emerging Major Histocompatibility Complex Class I-Related Functions of NLRC5.NLRC5 的新兴主要组织相容性复合体 I 相关功能。
Adv Immunol. 2017;133:89-119. doi: 10.1016/bs.ai.2016.11.003. Epub 2017 Jan 3.
9
The N-terminal domain of NLRC5 confers transcriptional activity for MHC class I and II gene expression.NLRC5的N端结构域赋予了MHC I类和II类基因表达的转录活性。
J Immunol. 2014 Sep 15;193(6):3090-100. doi: 10.4049/jimmunol.1401065. Epub 2014 Aug 15.
10
The MHC Class-I Transactivator NLRC5: Implications to Cancer Immunology and Potential Applications to Cancer Immunotherapy.MHC Class-I Transactivator NLRC5:对癌症免疫学的影响及在癌症免疫治疗中的潜在应用。
Int J Mol Sci. 2021 Feb 17;22(4):1964. doi: 10.3390/ijms22041964.

引用本文的文献

1
Immunotherapy resistance in non-small cell lung cancer: from mechanisms to therapeutic opportunities.非小细胞肺癌中的免疫治疗耐药性:从机制到治疗机遇
J Exp Clin Cancer Res. 2025 Aug 23;44(1):250. doi: 10.1186/s13046-025-03519-z.
2
Hsp90 and Isoform-Selective Inhibitors as Sensitizers for Cancer Immunotherapy.热休克蛋白90(Hsp90)及亚型选择性抑制剂作为癌症免疫治疗的增敏剂
Pharmaceuticals (Basel). 2025 Jul 10;18(7):1025. doi: 10.3390/ph18071025.
3
IFN-γ downregulates miR-4319 to enhance NLRC5 and MHC-I expression in MHC-I-deficient breast cancer cells.干扰素-γ下调miR-4319以增强MHC-I缺陷型乳腺癌细胞中NLRC5和MHC-I的表达。
Cancer Biol Ther. 2025 Dec;26(1):2523621. doi: 10.1080/15384047.2025.2523621. Epub 2025 Jul 1.
4
Inhibitory effect of Endostar on HIF-1 with upregulation of MHC-I in lung cancer cells.恩度对肺癌细胞中HIF-1的抑制作用及MHC-I的上调
Cancer Biol Ther. 2025 Dec;26(1):2508535. doi: 10.1080/15384047.2025.2508535. Epub 2025 May 20.
5
Down-Regulation of HLA-C Expression on Melanocytes May Contribute to the Therapeutic Efficacy of UVB Phototherapy in Psoriasis.黑素细胞上HLA - C表达的下调可能有助于UVB光疗对银屑病的治疗效果。
Int J Mol Sci. 2025 Mar 21;26(7):2858. doi: 10.3390/ijms26072858.
6
Orientia tsutsugamushi Ank5 promotes NLRC5 cytoplasmic retention and degradation to inhibit MHC class I expression.恙虫东方体 Ank5 促进 NLRC5 细胞质滞留和降解,抑制 MHC Ⅰ类分子表达。
Nat Commun. 2024 Sep 14;15(1):8069. doi: 10.1038/s41467-024-52119-6.
7
NLRC5 exerts anti-endometriosis effects through inhibiting ERβ-mediated inflammatory response.NLRC5 通过抑制 ERβ 介导的炎症反应发挥抗子宫内膜异位症作用。
BMC Med. 2024 Sep 2;22(1):351. doi: 10.1186/s12916-024-03571-0.
8
Identification of an immune-related signature as a prognostic classifier for patients with early-stage head and neck squamous cell carcinoma.鉴定一种免疫相关特征作为早期头颈部鳞状细胞癌患者的预后分类器。
Transl Cancer Res. 2024 Mar 31;13(3):1367-1381. doi: 10.21037/tcr-23-1791. Epub 2024 Mar 27.
9
NLRC5 overexpression in ovarian tumors remodels the tumor microenvironment and increases T-cell reactivity toward autologous tumor-associated antigens.NLRC5 在卵巢肿瘤中的过表达重塑了肿瘤微环境,并增加了 T 细胞对自体肿瘤相关抗原的反应性。
Front Immunol. 2024 Jan 3;14:1295208. doi: 10.3389/fimmu.2023.1295208. eCollection 2023.
10
Eribulin is an immune potentiator in breast cancer that upregulates human leukocyte antigen class I expression via the induction of NOD-like receptor family CARD domain-containing 5.艾立布林是一种乳腺癌的免疫增强剂,通过诱导核苷酸结合寡聚化结构域样受体家族含 CARD 结构域蛋白 5,上调人类白细胞抗原 I 类的表达。
Cancer Sci. 2023 Dec;114(12):4511-4520. doi: 10.1111/cas.15986. Epub 2023 Nov 22.

本文引用的文献

1
Transcriptional Upregulation of NLRC5 by Radiation Drives STING- and Interferon-Independent MHC-I Expression on Cancer Cells and T Cell Cytotoxicity.辐射转录上调 NLRC5 驱动肿瘤细胞上的 STING 和干扰素非依赖性 MHC-I 表达和 T 细胞细胞毒性。
Sci Rep. 2020 Apr 30;10(1):7376. doi: 10.1038/s41598-020-64408-3.
2
Tim-3 Promotes Listeria monocytogenes Immune Evasion by Suppressing Major Histocompatibility Complex Class I.Tim-3 通过抑制主要组织相容性复合体 I 促进李斯特菌的免疫逃逸。
J Infect Dis. 2020 Feb 18;221(5):830-840. doi: 10.1093/infdis/jiz512.
3
NLRC5 negatively regulates LTA-induced inflammation via TLR2/NF-κB and participates in TLR2-mediated allergic airway inflammation.NLRC5 通过 TLR2/NF-κB 负调控 LTA 诱导的炎症反应,并参与 TLR2 介导的过敏性气道炎症。
J Cell Physiol. 2019 Nov;234(11):19990-20001. doi: 10.1002/jcp.28596. Epub 2019 Apr 3.
4
NLRC5 deficiency has a moderate impact on immunodominant CD8 T-cell responses during rotavirus infection of adult mice.NLRC5 缺乏对成年小鼠轮状病毒感染期间免疫显性 CD8 T 细胞应答有中等影响。
Immunol Cell Biol. 2019 Jul;97(6):552-562. doi: 10.1111/imcb.12244. Epub 2019 Mar 29.
5
Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance.I 类转录激活物 NLRC5:MHC I 类途径和癌症免疫监视的核心参与者。
Immunogenetics. 2019 Mar;71(3):273-282. doi: 10.1007/s00251-019-01106-z. Epub 2019 Jan 31.
6
The Obligate Intracellular Bacterium Targets NLRC5 To Modulate the Major Histocompatibility Complex Class I Pathway.专性细胞内细菌靶向 NLRC5 调节主要组织相容性复合物 I 类途径。
Infect Immun. 2019 Feb 21;87(3). doi: 10.1128/IAI.00876-18. Print 2019 Mar.
7
NLRC5 mediates cell proliferation, migration, and invasion by regulating the Wnt/β-catenin signalling pathway in clear cell renal cell carcinoma.NLRC5 通过调节肾透明细胞癌中的 Wnt/β-连环蛋白信号通路来介导细胞增殖、迁移和侵袭。
Cancer Lett. 2019 Mar 1;444:9-19. doi: 10.1016/j.canlet.2018.11.024. Epub 2018 Dec 11.
8
High Expression of NLRC5 Is Associated with Prognosis of Gastric Cancer.NLRC5高表达与胃癌预后相关。
Open Med (Wars). 2018 Oct 4;13:443-449. doi: 10.1515/med-2018-0066. eCollection 2018.
9
Regulatory NLRs Control the RLR-Mediated Type I Interferon and Inflammatory Responses in Human Dendritic Cells.调控性 NLR 家族蛋白控制人类树突状细胞中 RLR 介导的 I 型干扰素和炎症反应。
Front Immunol. 2018 Oct 5;9:2314. doi: 10.3389/fimmu.2018.02314. eCollection 2018.
10
Quiescent Tissue Stem Cells Evade Immune Surveillance.静止组织干细胞逃避免疫监视。
Immunity. 2018 Feb 20;48(2):271-285.e5. doi: 10.1016/j.immuni.2018.02.001.

MHC Ⅰ类转录激活因子 NLRC5 在宿主免疫、癌症及其他方面的作用

MHC class I transactivator NLRC5 in host immunity, cancer and beyond.

机构信息

Department of Immunology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.

Department of Microbial Pathogenesis and Immunology, Texas A&M Health Science Center, College Station, TX, USA.

出版信息

Immunology. 2021 Mar;162(3):252-261. doi: 10.1111/imm.13235. Epub 2020 Aug 3.

DOI:10.1111/imm.13235
PMID:32633419
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7884647/
Abstract

The presentation of antigenic peptides by major histocompatibility complex (MHC) class I and class II molecules is crucial for activation of the adaptive immune system. The nucleotide-binding domain and leucine-rich repeat receptor family members CIITA and NLRC5 function as the major transcriptional activators of MHC class II and class I gene expression, respectively. Since the identification of NLRC5 as the master regulator of MHC class I and class-I-related genes, there have been major advances in understanding the function of NLRC5 in infectious diseases and cancer. Here, we discuss the biological significance and mechanism of NLRC5-dependent MHC class I expression.

摘要

主要组织相容性复合体 (MHC) Ⅰ类和Ⅱ类分子呈递抗原肽对于适应性免疫系统的激活至关重要。核苷酸结合域和富含亮氨酸重复受体家族成员 CIITA 和 NLRC5 分别作为 MHC Ⅱ类和Ⅰ类基因表达的主要转录激活因子发挥作用。自从 NLRC5 被鉴定为 MHC Ⅰ类和Ⅰ类相关基因的主调控因子以来,人们对 NLRC5 在传染病和癌症中的功能有了更深入的了解。在这里,我们讨论了 NLRC5 依赖性 MHC Ⅰ类表达的生物学意义和机制。